Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic
Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic
复制标题
DOI：
10.1016/j.wneu.2020.05.140
复制
发表时间：
2020-07-01
影响因子：
2
通讯作者：
Zacharia, Brad E.
中科院分区：
文献类型：
--
作者：
Daggubati, Lekhaj C.;Eichberg, Daniel G.;Zacharia, Brad E.
背景技术背景：2019冠状病毒（COVD-19）大流行严重扰乱了神经外科护理的提供，特别是对于已经处于风险中的神经肿瘤人群。诊所访问的突然变化迅速摒弃了远程医疗的实施。一个建议的护理模式的神经肿瘤患者有限的远程medicine.METHODS：一个多机构的经验总结，详细说明了潜在的好处，陷阱，和必要的考虑因素，神经外科肿瘤患者的门诊护理。- 结果：将远程医疗纳入神经肿瘤患者的门诊护理有其局限性和优势。远程医疗的每一个步骤和利益相关者的任命（医生，病人，调度，previsit，成像和体检）的具体考虑examined.CONCLUSIONS：远程医疗，推到突出在这个COVID-19大流行期间，是一个强大的，可能是优先的工具，为未来的门诊神经肿瘤护理。
BACKGROUND: The coronavirus 2019 (COVD-19) pandemic has drastically disrupted the delivery of neurosurgical care, especially for the already at-risk neuro-oncology population. The sudden change to clinic visits has rapidly spurned the implementation of telemedicine. A recommendation care paradigm of neuro-oncologic patients limited by telemedicine has not been reported.METHODS: A summary of a multi-institution experience detailing the potential benefits, pitfalls, and the necessary considerations to outpatient care of neurosurgical oncology patients. -RESULTS: There are limitations and advantages to incorporating telemedicine into the outpatient care of neuro-oncology patients. Telemedicine-specific considerations for each step and stakeholder of the appointment (physician, patient, scheduling, previsit, imaging, and physical examination) are examined.CONCLUSIONS: Telemedicine, pushed to prominence during this COVID-19 pandemic, is a powerful and possibly preferential tool for the future of outpatient neurooncologic care.